- Home
- ALLR vs CXAI Comparison
ALLR vs CXAI Comparison
Compare ALLR & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- CXAI
- Stock Information
- Founded
- ALLR 2004
- CXAI N/A
- Country
- ALLR United States
- CXAI United States
- Employees
- ALLR N/A
- CXAI N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- CXAI EDP Services
- Sector
- ALLR Health Care
- CXAI Technology
- Exchange
- ALLR Nasdaq
- CXAI Nasdaq
- Market Cap
- ALLR 15.8M
- CXAI 17.8M
- IPO Year
- ALLR N/A
- CXAI N/A
- Fundamental
- Price
- ALLR $1.73
- CXAI $0.85
- Analyst Decision
- ALLR Strong Buy
- CXAI
- Analyst Count
- ALLR 1
- CXAI 0
- Target Price
- ALLR $9.25
- CXAI N/A
- AVG Volume (30 Days)
- ALLR 641.5K
- CXAI 734.5K
- Earning Date
- ALLR 11-13-2025
- CXAI 11-11-2025
- Dividend Yield
- ALLR N/A
- CXAI N/A
- EPS Growth
- ALLR N/A
- CXAI N/A
- EPS
- ALLR N/A
- CXAI N/A
- Revenue
- ALLR N/A
- CXAI $6,005,000.00
- Revenue This Year
- ALLR N/A
- CXAI N/A
- Revenue Next Year
- ALLR N/A
- CXAI $60.00
- P/E Ratio
- ALLR N/A
- CXAI N/A
- Revenue Growth
- ALLR N/A
- CXAI N/A
- 52 Week Low
- ALLR $0.61
- CXAI $0.61
- 52 Week High
- ALLR $2.35
- CXAI $2.54
- Technical
- Relative Strength Index (RSI)
- ALLR 58.71
- CXAI 61.69
- Support Level
- ALLR $1.54
- CXAI $0.79
- Resistance Level
- ALLR $1.65
- CXAI $0.88
- Average True Range (ATR)
- ALLR 0.13
- CXAI 0.06
- MACD
- ALLR -0.01
- CXAI 0.02
- Stochastic Oscillator
- ALLR 72.97
- CXAI 86.49
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.